Medpace Holdings (NASDAQ: MEDP) reported Q1 EPS of $0.64, $0.05 better than the analyst estimate of $0.59. Revenue for the quarter came in at $200.7 million versus the consensus estimate of $190.33 million.

• Revenue of $200.7 million in the first quarter of 2019 increased 23.1% from revenue of $163.1 million for the comparable prior-year period, representing a backlog conversion rate of 19.0%.
• Net new business awards were $248.7 million in the first quarter of 2019, representing an increase of 23.9% from net new business awards of $200.7 million for the comparable prior-year period, which resulted in a net book-to-bill ratio of 1.24x.
• First quarter of 2019 GAAP net income was $19.2 million, or $0.51 per diluted share, versus GAAP net income of $14.6 million, or $0.40 per diluted share, for the comparable prior-year period. Net income margin was 9.6% and 8.9% for the first quarter of 2019 and 2018, respectively.
• EBITDA was $33.4 million for the first quarter of 2019, an increase of 12.7% from EBITDA of $29.7 million for the comparable prior-year period, resulting in an EBITDA margin of 16.7%.
• Adjusted Net Income was $23.8 million, or $0.64 per diluted share, for the first quarter of 2019, an increase of 18.9% from the comparable prior-year period.

GUIDANCE:

Medpace Holdings sees FY2019 EPS of $2.58-$2.69, versus the consensus of $2.64. Medpace Holdings sees FY2019 revenue of $813-837 million, versus the consensus of $795.05 million.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.